AI-generated summary
The authors randomized 83 adults with type 2 diabetes and depression to 4 weeks of bright light therapy or placebo light at home. Light therapy was not superior to placebo on depressive symptoms or insulin sensitivity in the main analysis. Secondary subgroup analyses suggested possible benefit in highly insulin-resistant participants, which the authors describe as preliminary and the trial as essentially inconclusive.
- Participants
- 83
- Who or what was studied
- Adults with depression and type 2 diabetes
- Limits stated in the abstract
- The authors describe the trial as essentially inconclusive, with the positive subgroup findings coming from prespecified but secondary analyses.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on diabetesjournals.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Placebo-controlled, Intention-to-treat analysis, Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.